Skip to main content

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 400+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • · Every release, the moment it crosses — not a daily digest
  • · Search and filter the full archive, not the last 24 hours
  • · Instant alerts on saved searches

PPN World — real-time press release intelligence.

Dasher Neuroscience achève le recrutement des patients dans le cadre de l'essai clinique mondial de phase II portant sur le YA-101, son principal candidat-médicament développé grâce à l'IA, destiné au traitement de l'atrophie multisystématisée (AMS) · PR Newswire (US) · PPN World